Galectin 2 Polyclonal antibody

Galectin 2 Polyclonal Antibody for IHC, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 12849-2-AP

Synonyms

Gal 2, Galectin 2, HL14, Lactose binding lectin 2, LGALS2, S Lac lectin 2



Tested Applications

Positive WB detected inmouse small intestine tissue, rat small intestine tissue
Positive IHC detected inhuman colon cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Sample-dependent, check data in validation data gallery

Product Information

12849-2-AP targets Galectin 2 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Galectin 2 fusion protein Ag3979
Full Name lectin, galactoside-binding, soluble, 2
Calculated molecular weight 132 aa, 15 kDa
Observed molecular weight 15 kDa
GenBank accession numberBC029063
Gene symbol LGALS2
Gene ID (NCBI) 3957
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for Galectin 2 antibody 12849-2-APDownload protocol
IHC protocol for Galectin 2 antibody 12849-2-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Oncotarget

Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

Authors - Maria Claudia Vladoiu
humanWB,IHC

J Gastroenterol

Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer.

Authors - Jung Ji-Han JH
humanIHC

Oncotarget

Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.

Authors - Andrée-Anne Grosset